ReviewAdvanced pharmaceutical bulletin2023

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy.

Somayyeh Ghareghomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.